Diana Hausman insider trades
Open-market stock purchases and sales by Diana Hausman, Director at Immuneering Corp, from SEC Form 4 filings since Dec 12, 2012.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +29%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | IMRX Immuneering Corp | Bought (not open market) | — |